Maximilian Johannes Hochmair (Maximilian J Hochmair, Maximilian Hochmair, Maximillian J Hochmair)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 23

Top Venues

Cancers

Exploration of targeted anti-tumor therapy

International journal of molecular sciences

Future oncology (London, England)

Sozialmedizinisches Zentrum Baumgartner Höhe Otto Wagner Spital mit Pflegezentrum

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sozialmedizinisches Zentrum Baumgartner Höhe Otto Wagner Spital mit Pflegezentrum

Austria

Oberazt :: Respiratory Oncology Unit

Publications

Oliver Illini, Felix Carl Saalfeld, Petros Christopoulos, Michaël Duruisseaux, Anders Vikström, Nir Peled, Ingel Demedts, Elizabeth Dudnik, Anna Eisert, Sayed M S Hashemi, Urska Janzic, Waleed Kian, Katja Mohorcic, Saara Mohammed, Maria Silvoniemi, Sacha I Rothschild, Christian Schulz, Claas Wesseler, Alfredo Addeo, Karin Armster, Malinda Itchins, Marija Ivanović, Diego Kauffmann-Guerrero, Jussi Koivunen, Jonas Kuon, Nick Pavlakis, Berber Piet, Martin Sebastian, Janna-Lisa Velthaus-Rusik, Luciano Wannesson, Marcel Wiesweg, Robert Wurm, Corinna Albers-Leischner, Daniela E Aust, Melanie Janning, Hannah Fabikan, Sylvia Herold, Anna Klimova, Sonja Loges, Yana Sharapova, Maret Schütz, Christoph Weinlinger, Arschang Valipour, Tobias Raphael Overbeck, Frank Griesinger, Marko Jakopovic, Maximilian Johannes Hochmair, Martin Wermke
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis. International journal of molecular sciences 25 (7) (2024)
Maximilian Johannes Hochmair, Angelika Terbuch, David Lang, Christian Trockenbacher, Florian Augustin, Bahil D Ghanim, Dominik Maurer, Hossein Taghizadeh, Christoph Kamhuber, Robert Wurm, Joerg Lindenmann, Petra Braz, Tatjana Bundalo, Merjem Begic, Johanna Bauer, Patrick Reimann, Nino Müser, Florian Huemer, Verena Schlintl, Daniela Bianconi, Bernhard Baumgartner, Peter Schenk, Markus Rauter, Konrad Hötzenecker
Real-World Treatment Patterns and Timeliness of Clinical Care Pathway for Non-Small Cell Lung Cancer Patients in Austria: The PRATER Retrospective Study. Cancers 16 (14) (2024)
Maximilian Johannes Hochmair, Angelika Terbuch, David Lang, Christian Trockenbacher, Florian Augustin, Bahil D Ghanim, Dominik Maurer, Hossein Taghizadeh, Christoph Kamhuber, Robert Wurm, Joerg Lindenmann, Petra Braz, Tatjana Bundalo, Merjem Begic, Johanna Bauer, Patrick Reimann, Nino Müser, Florian Huemer, Verena Schlintl, Daniela Bianconi, Bernhard Baumgartner, Peter Schenk, Markus Rauter, Konrad Hötzenecker
Real-World Treatment Patterns and Timeliness of Clinical Care Pathway for Non-Small Cell Lung Cancer Patients in Austria: The PRATER Retrospective Study. Cancers 16 (14) (2024)
Oliver Illini, Felix Carl Saalfeld, Petros Christopoulos, Michaël Duruisseaux, Anders Vikström, Nir Peled, Ingel Demedts, Elizabeth Dudnik, Anna Eisert, Sayed M S Hashemi, Urska Janzic, Waleed Kian, Katja Mohorcic, Saara Mohammed, Maria Silvoniemi, Sacha I Rothschild, Christian Schulz, Claas Wesseler, Alfredo Addeo, Karin Armster, Malinda Itchins, Marija Ivanović, Diego Kauffmann-Guerrero, Jussi Koivunen, Jonas Kuon, Nick Pavlakis, Berber Piet, Martin Sebastian, Janna-Lisa Velthaus-Rusik, Luciano Wannesson, Marcel Wiesweg, Robert Wurm, Corinna Albers-Leischner, Daniela E Aust, Melanie Janning, Hannah Fabikan, Sylvia Herold, Anna Klimova, Sonja Loges, Yana Sharapova, Maret Schütz, Christoph Weinlinger, Arschang Valipour, Tobias Raphael Overbeck, Frank Griesinger, Marko Jakopovic, Maximilian Johannes Hochmair, Martin Wermke
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis. International journal of molecular sciences 25 (7) (2024)
Maximilian Johannes Hochmair, Angelika Terbuch, David Lang, Christian Trockenbacher, Florian Augustin, Bahil D Ghanim, Dominik Maurer, Hossein Taghizadeh, Christoph Kamhuber, Robert Wurm, Joerg Lindenmann, Petra Braz, Tatjana Bundalo, Merjem Begic, Johanna Bauer, Patrick Reimann, Nino Müser, Florian Huemer, Verena Schlintl, Daniela Bianconi, Bernhard Baumgartner, Peter Schenk, Markus Rauter, Konrad Hötzenecker
Real-World Treatment Patterns and Timeliness of Clinical Care Pathway for Non-Small Cell Lung Cancer Patients in Austria: The PRATER Retrospective Study. Cancers 16 (14) (2024)
Oliver Illini, Felix Carl Saalfeld, Petros Christopoulos, Michaël Duruisseaux, Anders Vikström, Nir Peled, Ingel Demedts, Elizabeth Dudnik, Anna Eisert, Sayed M S Hashemi, Urska Janzic, Waleed Kian, Katja Mohorcic, Saara Mohammed, Maria Silvoniemi, Sacha I Rothschild, Christian Schulz, Claas Wesseler, Alfredo Addeo, Karin Armster, Malinda Itchins, Marija Ivanović, Diego Kauffmann-Guerrero, Jussi Koivunen, Jonas Kuon, Nick Pavlakis, Berber Piet, Martin Sebastian, Janna-Lisa Velthaus-Rusik, Luciano Wannesson, Marcel Wiesweg, Robert Wurm, Corinna Albers-Leischner, Daniela E Aust, Melanie Janning, Hannah Fabikan, Sylvia Herold, Anna Klimova, Sonja Loges, Yana Sharapova, Maret Schütz, Christoph Weinlinger, Arschang Valipour, Tobias Raphael Overbeck, Frank Griesinger, Marko Jakopovic, Maximilian Johannes Hochmair, Martin Wermke
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis. International journal of molecular sciences 25 (7) (2024)
Gerhard Hamilton, Maximilian Johannes Hochmair, Sandra Stickler
Overcoming resistance in small-cell lung cancer. Expert review of respiratory medicine (2024)
Gerhard Hamilton, Maximilian Johannes Hochmair, Sandra Stickler
Overcoming resistance in small-cell lung cancer. Expert review of respiratory medicine (2024)
Luis G Paz-Ares, Marina-Chiara Garassino, Yuanbin Chen, Niels Reinmuth, Katsuyuki Hotta, Artem Poltoratskiy, Dmytro Trukhin, Maximilian Johannes Hochmair, Mustafa Özgüroğlu, Jun Ho Ji, Galina Statsenko, Nikolay Vladimirov Conev, Igor Bondarenko, Libor Havel, György Losonczy, Mingchao Xie, Zhongwu Lai, Nadia Godin-Heymann, Helen Mann, Haiyi Jiang, Yashaswi Shrestha, Jonathan Wade Goldman
Durvalumab ± tremelimumab + platinum-etoposide in extensive-stage small-cell lung cancer (CASPIAN): outcomes by PD-L1 expression and tissue tumor mutational burden. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Michal Benej, Thomas Klikovits, Tibor Krajc, Tomas Bohanes, Lisa Schulte, Maximilian Johannes Hochmair, Stefan B Watzka, Berta Mosleh, Konrad Hoetzenecker, Clemens Aigner, Mir Alireza Hoda, Michael Rolf Mueller
Lymph Node Log-Odds Ratio Accurately Defines Prognosis in Resectable Non-Small Cell Lung Cancer. Cancers 15 (7) (2023)
Irina Robinson, Maximilian Johannes Hochmair, Manuela Schmidinger, Gudrun Absenger, Martin Pichler, Van Anh Nguyen, Erika Richtig, Barbara Margaretha Rainer, Leyla Ay, Christian Jansen, Cátia Pacífico, Alexander Knabl, Barbara Sladek, Nikolaus Gasche, Arschang Valipour
Assessing the Performance of a Novel Stool-Based Microbiome Test That Predicts Response to First Line Immune Checkpoint Inhibitors in Multiple Cancer Types. Cancers 15 (13) (2023)
Barbara Rath, Adelina Plangger, Lukas Klameth, Maximilian Johannes Hochmair, Ernst Ulsperger, Bram Boeckx, Christoph Neumayer, Gerhard Hamilton
Small cell lung cancer: circulating tumor cell lines and expression of mediators of angiogenesis and coagulation. Exploration of targeted anti-tumor therapy 4 (2) (2023)
Barbara Rath, Adelina Plangger, Lukas Klameth, Maximilian Johannes Hochmair, Ernst Ulsperger, Bram Boeckx, Christoph Neumayer, Gerhard Hamilton
Small cell lung cancer: circulating tumor cell lines and expression of mediators of angiogenesis and coagulation. Exploration of targeted anti-tumor therapy 4 (2) (2023)
Barbara Rath, Adelina Plangger, Lukas Klameth, Maximilian Johannes Hochmair, Ernst Ulsperger, Bram Boeckx, Christoph Neumayer, Gerhard Hamilton
Small cell lung cancer: circulating tumor cell lines and expression of mediators of angiogenesis and coagulation. Exploration of targeted anti-tumor therapy 4 (2) (2023)
Romana Wass, Maximilian Johannes Hochmair, Bernhard Kaiser, Brane Grambozov, Petra Feurstein, Gertraud Weiß, Raphaela Moosbrugger, Felix Sedlmayer, Bernd Lamprecht, Michael Studnicka, Franz Zehentmayr
Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Trospective Comparison Focusing on Pulmonary Toxicity. Cancers 14 (13) (2022)
Oliver Illini, Hannah Fabikan, Maximilian Johannes Hochmair, Christoph Weinlinger, Dagmar Krenbek, Luka Brcic, Ulrike Setinek, Angelika Terbuch, Gudrun Absenger, Selma Konjić, Arschang Valipour
Characteristics and Treatment Outcomes in Advanced-Stage Non-Small Cell Lung Cancer Patients with a KRAS G12C Mutation: A Real-World Study. Journal of clinical medicine 11 (14) (2022)
Oliver Illini, Arschang Valipour, Dietlinde Gattinger, Milos Petrovic, Hannah Fabikan, Maximilian Johannes Hochmair, Ralf Harun Zwick
Effectiveness of Outpatient Pulmonary Rehabilitation in Patients with Surgically Resected Lung Cancer: A Retrospective Real-World Analysis. Cancers 14 (14) (2022)
Arnulf Holzknecht, Oliver Illini, Maximilian Johannes Hochmair, Dagmar Krenbek, Ulrike Setinek, Florian Huemer, Erwin Bitterlich, Christoph Kaindl, Vladyslav Getman, Ahmet Akan, Michael Weber, Gunther Leobacher, Arschang Valipour, Michael R Mueller, Stefan B Watzka
Multimodal Treatment of Malignant Pleural Mesothelioma: Real-World Experience with 112 Patients. Cancers 14 (9) (2022)
Eva Obermayr, Nina Koppensteiner, Nicole Heinzl, Eva Schuster, Barbara Holzer, Hannah Fabikan, Christoph Weinlinger, Oliver Illini, Maximilian Johannes Hochmair, Robert Zeillinger
Cancer Stem Cell-Like Circulating Tumor Cells Are Prognostic in Non-Small Cell Lung Cancer. Journal of personalized medicine 11 (11) (2021)
Anna Buder, Ellen Heitzer, Julie Waldispühl-Geigl, Sabrina Weber, Tina Moser, Maximilian Johannes Hochmair, Klaus Hackner, Peter Errhalt, Ulrike Setinek, Martin Filipits
Somatic Copy-Number Alterations in Plasma Circulating Tumor DNA from Advanced EGFR-Mutated Lung Adenocarcinoma Patients. Biomolecules 11 (5) (2021)
Bruce A Feinberg, Balazs Halmos, Rasim Gucalp, Wenbo Tang, Barbara Moehring, Maximilian Johannes Hochmair
Making the case for EGFR TKI sequencing in EGFR mutation-positive NSCLC: a GioTag study US patient analysis. Future oncology (London, England) 16 (22) (2020)
Maximilian Johannes Hochmair, Hannah Fabikan, Oliver Illini, Christoph Weinlinger, Ulrike Setinek, Dagmar Krenbek, Helmut Prosch, Markus Rauter, Michael Schumacher, Ewald Wöll, Romana Wass, Elmar Brehm, Gudrun Absenger, Tatjana Bundalo, Peter Errhalt, Matthias Urban, Arschang Valipour
Later-Line Treatment with Lorlatinib in ALK- and ROS1-Rearrangement-Positive NSCLC: A Retrospective, Multicenter Analysis. Pharmaceuticals (Basel, Switzerland) 13 (11) (2020)
Maximilian Johannes Hochmair, Alessandro Morabito, Desiree Hao, Cheng-Ta Yang, Ross A Soo, James C-H Yang, Rasim Gucalp, Balazs Halmos, Angela Märten, Tanja Cufer
Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: final analysis of the GioTag study. Future oncology (London, England) 16 (34) (2020)

Maximilian Johannes Hochmair.css-eqlu8i{font-size:small;padding-left:4px;} (Maximilian J Hochmair, Maximilian Hochmair, Maximillian J Hochmair)

Publication Activity (10 Years)

Top Topics

Top Venues

Maximilian Johannes Hochmair (Maximilian J Hochmair, Maximilian Hochmair, Maximillian J Hochmair)